Cocrystal Pharma (NASDAQ:COCP) Shares Up 1.3%

Shares of Cocrystal Pharma, Inc. (NASDAQ:COCPGet Rating) rose 1.3% on Wednesday . The stock traded as high as $2.40 and last traded at $2.35. Approximately 36,861 shares changed hands during mid-day trading, a decline of 42% from the average daily volume of 63,915 shares. The stock had previously closed at $2.32.

Analyst Upgrades and Downgrades

Separately, HC Wainwright raised their price objective on Cocrystal Pharma to $42.00 and gave the stock a “buy” rating in a research report on Monday, November 7th.

Cocrystal Pharma Price Performance

The company’s 50-day moving average price is $2.43 and its two-hundred day moving average price is $3.48. The company has a market capitalization of $19.08 million, a price-to-earnings ratio of -0.50 and a beta of 1.04.

About Cocrystal Pharma

(Get Rating)

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections.

Featured Stories

Receive News & Ratings for Cocrystal Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cocrystal Pharma and related companies with MarketBeat.com's FREE daily email newsletter.